Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1100 mg AP1189----2件: 46, 222 💬
27-valent Pneumococcal Conjugate vaccine----2件: 46, 222 💬
3[Atrasentan]1件: Atrasentan1件: Atrasentan hydrochloride 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
4[BCX9930]----4件: 62, 66, 222, 223 💬
5[CCX140-B]----1件: 222 💬
6[Ioexolo]----1件: 222 💬
7[L01XC15]----1件: 222 💬
8[MOR202]----1件: 222 💬
9[over-encapsulated Irbesartan]1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
10[PF-06730512]----1件: 222 💬
11[R-021]----1件: 222 💬
12[RE-021]----3件: 66, 218, 222 💬
13[RO0485337]----1件: 222 💬
14[RO5072759]----1件: 222 💬
15[SUB08293MIG]----1件: 222 💬
16Abatacept1件: Abatacept1件: Abatacept 💬 2件: CD80,
CD86 💬 		14件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬28件: 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
17ACEI, SGLT-2i----1件: 222 💬
18ACEI/ARB----2件: 222, 224 💬
19ACEI/ARB+ finerenone1件: Finerenone1件: Finerenone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 222 💬
20Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
21Acetaminophen/ Paracetamol1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 222 💬
22Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
23Acetazolamide1件: Acetazolamide2件: Acetazolamide ,
Acetazolamide sodium 💬 		13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬 		6件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬8件: 13, 67, 90, 115, 155, 222, 225, 230 💬
24Acetazolamide and Hydrochlorothiazide Followed by Furosemide3件: Acetazolamide,
Furosemide,
Hydrochlorothiazide		4件: Acetazolamide ,
Furosemide ,
Hydrochlorothiazide ,
Acetazolamide sodium 💬 		15件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9,
SLC12A2,
SLC12A3 💬 		9件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Parathyroid hormone synthesis, secretion and action, Proximal tubule bicarbonate reclamation, Salivary secretion, Vibrio cholerae infection 💬1件: 222 💬
25Acid mycophenolic (Myfortic)----1件: 222 💬
26ACTH----3件: 13, 145, 222 💬
27Acthar----6件: 2, 13, 46, 49, 50, 222 💬
28Acthar Gel----6件: 13, 46, 49, 84, 222, 223 💬
29Acthar Gel 80 UNT/ML Injectable Solution----2件: 222, 223 💬
30Acthar Gel and Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
31Adalimumab1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬22件: 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
32Adalimumab (Humira)1件: Adalimumab1件: Adalimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 222, 271 💬
33Adoport----1件: 222 💬
34Adrenocorticotrophic Hormone----1件: 222 💬
35Adrenocorticotrophic hormone ACTH----2件: 222, 223 💬
36Advagraf 0,5mg----1件: 222 💬
37Advagraf 1mg----1件: 222 💬
38Advagraf 5mg----1件: 222 💬
39ADX-629----2件: 160, 222 💬
40AKF2328----2件: 222, 223 💬
41Aldosterone1件: Aldosterone1件: Aldosterone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬3件: 57, 75, 222 💬
42Alfacalcidol1件: Alfacalcidol1件: Alfacalcidol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 41, 46, 49, 50, 96, 107, 222, 223, 235, 238 💬
43Aliskiren1件: Aliskiren2件: Aliskiren ,
Aliskiren fumarate 💬 		1件: REN 💬 3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 66, 167, 222, 223 💬
44ALXN1920----1件: 222 💬
45Ambrisentan1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
46Amiloride1件: Amiloride2件: Amiloride hydrochloride ,
Amiloride 💬 		3件: SCNN1A,
SCNN1B,
SCNN1G 💬 		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬5件: 13, 67, 222, 225, 299 💬
47Amlodipine1件: Amlodipine4件: Amlodipine besylate ,
Amlodipine maleate ,
Amlodipine ,
Amlodipine benzoate 💬 		4件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		37件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 51, 67, 79, 113, 222, 298 💬
48Amoxicillin1件: Amoxicillin3件: Amoxicillin ,
Amoxicillin sodium ,
Amoxicillin 💬 		--9件: 6, 46, 63, 94, 96, 97, 222, 223, 299 💬
49Angiotensin II1件: Angiotensin II3件: Angiotensin II ,
Angiotensin II ,
Angiotensin II acetate 💬 		2件: AGTR1,
AGTR2 💬 		17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
50Anti-BCMA/CD70 CAR-T cells----1件: 222 💬
51Anti-CD19 CAR-T cells1件: Anti-CD19 CAR-T cells---6件: 46, 49, 50, 51, 53, 222 💬
52Anti-CD19/BCMA CAR NK cells (KN5601)----2件: 66, 222 💬
53Anticorps monoclonaux----1件: 222 💬
54AP1189----2件: 46, 222 💬
55Apixaban1件: Apixaban1件: Apixaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬6件: 48, 96, 97, 222, 223, 279 💬
56Apixaban 5 MG1件: Apixaban1件: Apixaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 222 💬
57APL-2----6件: 2, 61, 62, 66, 222, 223 💬
58APL2----1件: 222 💬
59Aprovel (150 mg)----1件: 222 💬
60Aprovel 150 mg Tablets----1件: 222 💬
61Arzerra----3件: 13, 222, 223 💬
62ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI----2件: 13, 222 💬
63Atacicept1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬 		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬5件: 13, 46, 49, 66, 222 💬
64ATG----6件: 13, 19, 60, 96, 222, 285 💬
65Atorvastatin1件: Atorvastatin2件: Atorvastatin calcium ,
Atorvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬21件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
66ATRASENTAN1件: Atrasentan1件: Atrasentan hydrochloride 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 66, 218, 222 💬
67Autologous mesenchymal stromal cells (MSC)----1件: 222 💬
68Azithromycin1件: Azithromycin3件: Azithromycin hydrate ,
Azithromycin ,
Azithromycin 💬 		--8件: 13, 84, 85, 96, 222, 228, 299, 340 💬
69B007----3件: 11, 35, 222 💬
70Bardoxolone1件: Bardoxolone1件: Bardoxolone 💬 --7件: 66, 67, 84, 85, 86, 218, 222 💬
71Bardoxolone methyl2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--7件: 66, 67, 84, 85, 86, 218, 222 💬
72Bardoxolone methyl capsules2件: Bardoxolone,
Bardoxolone methyl		2件: Bardoxolone ,
Bardoxolone methyl 💬 		--4件: 66, 67, 86, 222 💬
73Baseline Glucocorticoid Therapy----1件: 222 💬
74Basiliximab1件: Basiliximab1件: Basiliximab 💬 1件: IL2RA 💬 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬5件: 2, 50, 97, 222, 228 💬
75BAT4406F----2件: 13, 222 💬
76BCX9930----4件: 62, 66, 222, 223 💬
77BCX9930 hydrochloride----4件: 62, 66, 222, 223 💬
78Behavioral: Targeted Nursing Care----1件: 222 💬
79BELIMUMAB1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬17件: 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
80Belimumab 10 mg1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 222, 223 💬
81Benazepril1件: Benazepril2件: Benazepril hydrochloride ,
Benazepril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬5件: 49, 57, 218, 222, 224 💬
82Benlysta----7件: 43, 48, 49, 53, 63, 66, 222 💬
83Benlysta (belimumab)1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 49, 53, 222 💬
84Benlysta®----2件: 49, 222 💬
85BENLYSTA® (belimumab)1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 63, 66, 222 💬
86BI 764198----1件: 222 💬
87Bleselumab1件: Bleselumab1件: Bleselumab 💬 1件: CD40 💬 17件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Viral myocarditis 💬1件: 222 💬
88Blinatumomab1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬4件: 11, 46, 49, 222 💬
89Blinatumomab Treatment1件: Blinatumomab1件: Blinatumomab 💬 4件: CD19,
CD3D,
CD3E,
CD3G 💬 		13件: B cell receptor signaling pathway, Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 222 💬
90Blood and urine analysis----1件: 222 💬
91BMS-188667----10件: 46, 49, 53, 65, 96, 97, 107, 222, 223, 271 💬
92BORTEZOMIB1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬19件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
93Brivekimig----2件: 222, 223 💬
94Budoprutug1件: Budoprutug---3件: 49, 63, 222 💬
95Butyric Acid1件: Butyric Acid1件: Sodium butyrate 💬 --1件: 222 💬
96C03DB01----1件: 222 💬
97Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
98CANDESARTAN1件: Candesartan1件: Candesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬4件: 57, 58, 67, 222 💬
99CCX140-B----1件: 222 💬
100CD19 CAR-?d T cell----2件: 66, 222 💬
101CD19-targeted iNKT Cell Injection----3件: 66, 222, 223 💬
102CD19/BCMA-Targeted Universal Chimeric Antigen Receptor T Cells (UCAR-T) infusing----1件: 222 💬
103CELLCEPT----7件: 11, 13, 42, 43, 49, 222, 223 💬
104Cellule mesenchimali stromali di origine cordonale (CB-MSC) per uso allogenico)----1件: 222 💬
105CF-CB-MSC----1件: 222 💬
106Chlorambucil1件: Chlorambucil1件: Chlorambucil 💬 --2件: 222, 223 💬
107CHOLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬10件: 13, 19, 34, 46, 49, 96, 97, 222, 298, 299 💬
108Cholecalciferol vial (100 000 UI)1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 222 💬
109Cholesterol1件: Cholesterol1件: Cholesterol 💬 --10件: 8, 19, 71, 79, 90, 160, 222, 259, 261, 310 💬
110Ciclofosfamida----1件: 222 💬
111Ciclosporin soft capsules----1件: 222 💬
112Ciclosporina Generis 100 mg Cápsulas moles----1件: 222 💬
113Clarithromycin1件: Clarithromycin1件: Clarithromycin 💬 --10件: 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
114CliniMACS® TCR a/beta Reagent Kit and CliniMACS® CD19 System----3件: 19, 96, 222 💬
115CliniMACS® TCR a/ß Reagent Kit and CliniMACS® CD19 System----3件: 19, 96, 222 💬
116Clopidogrel1件: Clopidogrel4件: Clopidogrel bisulfate ,
Clopidogrel ,
Clopidogrel hydrochloride ,
Clopidogrel besilate 💬 		1件: P2RY12 💬 3件: Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬7件: 40, 49, 51, 62, 71, 86, 222 💬
117Co-intervention of Prednisolone wean during open label extension phase1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
118Co-intervention of Prednisolone wean during randomised controlled phase1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
119Conventional 24-week glucocorticoid regimen----1件: 222 💬
120Conventional Therapy----5件: 14, 49, 67, 97, 222 💬
121Corticosteroid----12件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
122Corticosteroids----13件: 41, 46, 49, 63, 64, 97, 107, 113, 164, 222, 223, 296, 300 💬
123Corticotropin1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬10件: 2, 13, 46, 75, 78, 81, 84, 145, 205, 222 💬
124Creatinine1件: Creatinine1件: Creatinine 💬 --9件: 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
125CTX combined with Glucocorticoids----1件: 222 💬
126CXA-101件: CXA-10---2件: 86, 222 💬
127Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
128Cyclophosphamide (CTX)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 28, 222 💬
129Cyclophosphamide 100 mg/Kg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
130Cyclophosphamide 1200 mg/Kg1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 19, 222 💬
131Cyclophosphamide and steroids1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--2件: 222, 223 💬
132Cyclosporin----6件: 53, 60, 97, 222, 223, 274 💬
133Cyclosporin A----12件: 46, 49, 53, 54, 56, 60, 63, 93, 95, 113, 164, 222 💬
134Cyclosporin Capsules----1件: 222 💬
135Cyclosporin, low dose steroid----2件: 222, 223 💬
136Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬39件: 11, 14, 19, 20, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 56, 58, 60, 61, 62, 63, 64, 65, 67, 90, 95, 97, 107, 118, 162, 164, 222, 223, 226, 228, 234, 283, 284, 285, 302 💬
137Cyclosporine Capsule1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
138Cyclosporins----4件: 53, 60, 65, 222 💬
139D-Galactose1件: Galactose1件: Galactose 💬 --1件: 222 💬
140Dacortín 2,5mg----1件: 222 💬
141Dacortín 30mg----1件: 222 💬
142Dacortín 5mg----1件: 222 💬
143Dalteparin1件: Dalteparin1件: Dalteparin sodium 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬3件: 222, 223, 327 💬
144Dandshen----1件: 222 💬
145Danzhu Fuyuan Granule----1件: 222 💬
146Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --16件: 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
147Dapagliflozin 10mg Tab1件: Dapagliflozin1件: Dapagliflozin 💬 --4件: 19, 97, 218, 222 💬
148Dapagliflozin and Standard therapy (ACEI or ARB).1件: Dapagliflozin1件: Dapagliflozin 💬 --1件: 222 💬
149Daratumumab1件: Daratumumab1件: Daratumumab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬13件: 13, 16, 28, 39, 46, 48, 49, 60, 63, 222, 223, 288, 331 💬
150Depakine Chrono 500©----1件: 222 💬
151DepoMedrol----3件: 70, 222, 223 💬
152Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬29件: 13, 14, 16, 19, 28, 35, 46, 53, 63, 64, 65, 70, 71, 74, 75, 81, 84, 90, 96, 97, 162, 222, 223, 235, 257, 283, 296, 299, 331 💬
153Diagnostic Test: =Urine analysis =Urine protein quantification =Serum albumin =Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.----1件: 222 💬
154Diagnostic Test: serum protein ,kidney function ,liver function.,serum cholesterol1件: Cholesterol1件: Cholesterol 💬 --1件: 222 💬
155Diovan (Valsartan/VAL489)1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
156Diphenhydramine1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬12件: 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
157Diphenhydramine hydrochloride1件: Diphenhydramine4件: Diphenhydramine ,
Diphenhydramine hydrochloride ,
Diphenhydramine salicylate ,
Diphenhydramine citrate 💬 		1件: HRH1 💬 4件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬3件: 11, 49, 222 💬
158Dipyridamole1件: Dipyridamole1件: Dipyridamole 💬 2件: PDE4A,
PDE5A 💬 		5件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 46, 49, 51, 66, 96, 222, 224 💬
159DMX-200----1件: 222 💬
160Dupilumab1件: Dupilumab1件: Dupilumab 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬8件: 51, 97, 98, 160, 162, 222, 300, 306 💬
161Dupilumab open label extension phase1件: Dupilumab1件: Dupilumab 💬 1件: IL4R 💬 8件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬1件: 222 💬
162Edoxaban1件: Edoxaban3件: Edoxaban tosilate hydrate ,
Edoxaban ,
Edoxaban tosylate 💬 		1件: F10 💬 1件: Complement and coagulation cascades 💬4件: 46, 71, 88, 222 💬
163Edoxaban 60 mg1件: Edoxaban3件: Edoxaban tosilate hydrate ,
Edoxaban ,
Edoxaban tosylate 💬 		1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 222 💬
164Efgartigimod IV1件: Efgartigimod alfa1件: Efgartigimod alfa 💬 --3件: 11, 63, 222 💬
165Eliquis----3件: 61, 222, 223 💬
166Elmisol----1件: 222 💬
167Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 --17件: 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
168Enalapril1件: Enalapril2件: Enalapril maleate ,
Enalapril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬
169ENDOXAN BAXTER*50CPR RIV 50MG----2件: 222, 223 💬
170Enoxaparin1件: Enoxaparin2件: Enoxaparin sodium ,
Adomiparin 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬6件: 46, 48, 71, 222, 223, 327 💬
171Enoxaparin 40 mg1件: Enoxaparin2件: Enoxaparin sodium ,
Adomiparin 💬 		1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 222 💬
172Entecavir1件: Entecavir2件: Entecavir ,
Entecavir 💬 		--8件: 46, 56, 96, 97, 107, 222, 223, 271 💬
173EVER001----2件: 66, 222 💬
174EVOLOCUMAB1件: Evolocumab1件: Evolocumab 💬 1件: PCSK9 💬 1件: Cholesterol metabolism 💬2件: 79, 222 💬
175Experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
176Fecal microbiota1件: Fecal microbiota---14件: 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
177Fecal microbiota transplantation (FMT)1件: Fecal microbiota---4件: 94, 96, 97, 222 💬
178Felzartamab1件: Felzartamab---2件: 66, 222 💬
179FG-3019----3件: 85, 113, 222 💬
180FILGOTINIB1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬10件: 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
181Finerenone1件: Finerenone1件: Finerenone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬5件: 66, 218, 222, 223, 224 💬
182FK506----1件: 222 💬
183FKC288----1件: 222 💬
184Fludarabine1件: Fludarabine2件: Fludarabine phosphate ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬30件: 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
185Fludarabine, Cyclophosphamide2件: Cyclophosphamide,
Fludarabine		4件: Cyclophosphamide ,
Fludarabine phosphate ,
Cyclophosphamide ,
Fludarabine 💬 		1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 60, 222 💬
186Fluvastatin1件: Fluvastatin2件: Fluvastatin sodium ,
Fluvastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬4件: 48, 79, 218, 222 💬
187Forxiga----4件: 86, 88, 222, 223 💬
188Fragmin----3件: 222, 223, 327 💬
189Fresolimumab1件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬3件: 51, 222, 274 💬
190Frexalimab1件: Frexalimab1件: Frexalimab 💬 1件: CD40LG 💬 14件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬3件: 13, 222, 223 💬
191Furosemid-ratiopharm® 40 mg1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 222 💬
192Furosemid-ratiopharm® 40 mgTabletten1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 222 💬
193Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬5件: 6, 57, 77, 86, 222 💬
194Furosemide and Hydrochlorothiazide Followed by Furosemide2件: Furosemide,
Hydrochlorothiazide		2件: Furosemide ,
Hydrochlorothiazide 💬 		2件: SLC12A2,
SLC12A3 💬 		4件: Pancreatic secretion, Parathyroid hormone synthesis, secretion and action, Salivary secretion, Vibrio cholerae infection 💬1件: 222 💬
195Furosemide Injection1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬2件: 6, 222 💬
196Galactose1件: Galactose1件: Galactose 💬 --4件: 66, 171, 222, 257 💬
197Gazyvaro----2件: 49, 222 💬
198GAZYVARO - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO - 1000MG/40ML - 1 FLACONCINO----1件: 222 💬
199GazyvaroProduct Name: ObinutuzumabProduct Code: RO5072759Pharmaceutical Form: Concentrate for solution for infusionINN or Proposed INN: ObinutuzumabCAS Number: 949142-50-1Current Sponsor code: RO5072759Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 1000-Trade Name: CellceptProduct Name: mycophenolate mofetilPharmaceutical Form: Film-coated tabletINN or Proposed INN: MYCOPHENOLATE MOFETILOther descriptive name: MYCOPHENOLATE MOFETILConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 500-Trade Name: CellceptProduct Name: mycophenolate mofetilPharmaceutical Form: Powder for oral suspensionINN or Proposed INN: MYCOPHENOLATE MOFETILOther descriptive name: MYCOPHENOLATE MOFETILConcentration unit: g/ml gram(s)/millilitreConcentration type: equalConcentration number: 0.2-----1件: 222 💬
200GAZYVARO® 1000 mg/40 mL----1件: 222 💬
201GC10081件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬2件: 85, 222 💬
202Genetic: DNA chip dedicated to the pharmacogenetic of steroids----1件: 222 💬
203Genetic: Genotyping of the NPHS2 variant rs61747728----1件: 222 💬
204Genetic: Multi-omics Analysis----1件: 222 💬
205Genotropin----6件: 13, 77, 107, 187, 193, 222 💬
206Genoxal----1件: 222 💬
207GFB-887----2件: 222, 223 💬
208Glucocorticoid + cytoxan----1件: 222 💬
209Glucocorticoid + tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
210Glucocorticoid combined with cyclophosphamide induction + maintenance1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 222 💬
211Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
212GSK1550188----5件: 11, 49, 63, 66, 222 💬
213GSK1550188 (Belimumab)1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬1件: 222 💬
214GZ402669----1件: 222 💬
215H.P. Acthar Gel----5件: 46, 49, 50, 84, 222 💬
216HS-10390 tablet----2件: 66, 222 💬
217Huaier granule----1件: 222 💬
218Huaiqihuang Granule----2件: 63, 222 💬
219HYDROCHLOROTHIAZIDE1件: Hydrochlorothiazide1件: Hydrochlorothiazide 💬 1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬5件: 13, 67, 222, 225, 235 💬
220Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬 		--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
221Hypertonic saline----3件: 222, 299, 340 💬
222IL-2 Low dose----1件: 222 💬
223Immunoglobulin IV----1件: 222 💬
224Immunoglobulines humaines normales----1件: 222 💬
225Indobufen1件: Indobufen1件: Indobufen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 222 💬
226INN not available yet----1件: 222 💬
227Intravenous (i.v.) methylprednisolone 1000 mg, total 91件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 222, 223 💬
228Intravenous injection----2件: 2, 222 💬
229INVIRASE----2件: 222, 223 💬
230Ioexolo----1件: 222 💬
231Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬8件: 11, 61, 62, 63, 66, 109, 222, 223 💬
232Irbesartan1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 57, 66, 167, 168, 222, 223 💬
233Irbesartan tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
234Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-031件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
235Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-03Product Name: over-encapsulated 75 mg Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
236Irbesartan tablets (NDC# 43547-0374-03 and NDC 43547-374-09, approved in the USA) Generic tablets distributed by Solco Healthcare US, LLCProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tablets (NDC# 31722-729-30 approved in the United states)Product Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021O1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
237Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
238Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
239Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Trade Name: Irbesartan tabletsProduct Name: over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-Trade Name: Irbesartan tabletsProduct Name: Over-encapsulated Irbesartan TabletsPharmaceutical Form: Capsule, hardINN or Proposed INN: IrbesartanCAS Number: 138402-11-6Other descriptive name: IRBESARTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 75-Product Name: SparsentanProduct Code: RE-021Pharmaceutical Form: TabletINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 400-1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
240IXP----1件: 222 💬
241Jianpixiaozhong particles and Wuse Dietotherapy----1件: 222 💬
242JMT601 Injection----1件: 222 💬
243Ketosteril----1件: 222 💬
244Kidney Transplant----2件: 19, 222 💬
245Lanraplenib1件: Lanraplenib1件: Lanraplenib 💬 --2件: 53, 222 💬
246Lansoprazole1件: Lansoprazole1件: Lansoprazole 💬 2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬8件: 63, 71, 85, 98, 166, 222, 223, 299 💬
247Lansoprazole, amoxicillin, clarithromycin3件: Amoxicillin,
Clarithromycin,
Lansoprazole		5件: Amoxicillin ,
Clarithromycin ,
Lansoprazole ,
Amoxicillin sodium ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 222, 223 💬
248Levamidole 50mg----1件: 222 💬
249Levamisole1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--4件: 60, 61, 62, 222 💬
250Levamisole 10 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
251Levamisole 10mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
252Levamisole 25 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
253Levamisole 25mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
254Levamisole 5 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
255Levamisole 50 mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
256Levamisole 5mg1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
257LEVAMISOLE CHLORHYDRATE1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--1件: 222 💬
258Levamisole hydrochloride1件: Levamisole2件: Levamisole hydrochloride ,
Levamisole 💬 		--2件: 60, 222 💬
259Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬9件: 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
260Lisinopril, losartan, and atorvastatin3件: Atorvastatin,
Lisinopril,
Losartan		6件: Losartan potassium ,
Lisinopril ,
Atorvastatin calcium ,
Atorvastatin ,
Lisinopril ,
Losartan 💬 		3件: ACE,
AGTR1,
HMGCR 💬 		22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
261LNP023----7件: 61, 62, 63, 66, 109, 222, 223 💬
262Long term tapering of prednisolone1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
263Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
264Losartan Tablets & QingReMoShen Granule1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
265LOSMAPIMOD1件: Losmapimod1件: Losmapimod 💬 4件: MAPK11,
MAPK12,
MAPK13,
MAPK14 💬 		64件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease, Diabetic cardiomyopathy, Dopaminergic synapse, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬2件: 113, 222 💬
266Mabthera----20件: 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
267MABTHERA - 1 FIALA 500 MG 50 ML----3件: 14, 53, 222 💬
268MabThera 100 mg concentrate for solution for infusion----1件: 222 💬
269MabThera 100mg----2件: 46, 222 💬
270MabThera 100mg concentrate for solution for infusion----1件: 222 💬
271MabThera 100mg, concentrate for solution for infusion----1件: 222 💬
272MabThera 500 mg concentrate for solution for infusion----2件: 46, 222 💬
273MabThera 500mg----2件: 46, 222 💬
274MABTHERA*EV 1FL 50ML 500MG----3件: 46, 222, 223 💬
275MabThéra 100mg----1件: 222 💬
276MabThéra 500mg----1件: 222 💬
277ManNAc----1件: 222 💬
278Medrol----4件: 13, 46, 56, 222 💬
279MEDROL*10CPR DIV 4MG----2件: 222, 223 💬
280Melphalan1件: Melphalan2件: Melphalan ,
Melphalan hydrochloride 💬 		--19件: 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
281Mesenchymal stem cells----16件: 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
282Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬31件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
283Metformin + Standard of Care1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 222 💬
284Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
285METHYLPREDNISOLONE SODIUM SUCCINATE3件: Methylprednisolone,
Methylprednisolone hemisuccinate,
Succinic acid		4件: Methylprednisolone ,
Methylprednisolone sodium succinate ,
Methylprednisolone acetate ,
Methylprednisolone hemisuccinate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬7件: 13, 46, 49, 50, 51, 211, 222 💬
286Methylprednisone1件: Methylprednisone---4件: 46, 66, 85, 222 💬
287Metolazone1件: Metolazone1件: Metolazone 💬 1件: SLC12A3 💬 1件: Parathyroid hormone synthesis, secretion and action 💬1件: 222 💬
288MIL62----3件: 13, 49, 222 💬
289Mizoribine1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 46, 49, 51, 53, 66, 94, 222, 224 💬
290Mizoribine (MZR)1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬1件: 222 💬
291MMF----4件: 40, 51, 60, 222 💬
292MMF and Dexamethasone1件: Dexamethasone3件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
293Modamide 5 mg tablet----1件: 222 💬
294Modified Ponticelli regimen----1件: 222 💬
295Montelukast1件: Montelukast2件: Montelukast sodium ,
Montelukast 💬 		1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬10件: 6, 13, 19, 46, 61, 63, 85, 98, 222, 228 💬
296MOR03087----2件: 66, 222 💬
297MOR202----3件: 66, 222, 223 💬
298MP and CTX----1件: 222 💬
299Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
300Mycophenolate mofetil (MMF)1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 13, 49, 51, 60, 65, 66, 222, 223 💬
301Mycophenolate mofetil orally 1000 mg twice a day (BID)1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 222, 223 💬
302Mycophenolate mofetil, low dose steroid1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 222, 223 💬
303Mycophenolate sodium1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬6件: 49, 53, 66, 222, 223, 228 💬
304Mycophenolatmofetile----1件: 222 💬
305Mycophenolic acid1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬 		2件: IMPDH1,
IMPDH2 💬 		2件: Drug metabolism - other enzymes, Purine metabolism 💬9件: 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
306Mycophenolic sodium----3件: 66, 222, 223 💬
307Mycophenylate mofetil----4件: 19, 20, 222, 223 💬
308Mycopheylate mofetil----2件: 222, 223 💬
309Myfenax----2件: 222, 223 💬
310Myfortic----5件: 49, 66, 222, 223, 228 💬
311Myfortic 180mg Tablets----3件: 66, 222, 223 💬
312Myfortic 360mg Tablets----3件: 66, 222, 223 💬
313Myfortic plus low-dose steroid----1件: 222 💬
314Narsoplimab1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬3件: 66, 222, 223 💬
315NC-503 (Anti-amyloidotic (AA) Agent)----2件: 46, 222 💬
316Neoral----3件: 60, 97, 222 💬
317NKX019----4件: 46, 49, 51, 222 💬
318None----14件: 13, 46, 65, 84, 85, 96, 97, 106, 160, 161, 171, 222, 223, 299 💬
319None yet----3件: 51, 85, 222 💬
320Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 43, 44, 49, 63, 222, 223 💬
321Obinutuzumab administration1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 49, 222 💬
322Obinutuzumab Injection1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
323OBINUTUZUMAB/ GA1011件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
324Obitunuzumab----1件: 222 💬
325Ofatumumab1件: Ofatumumab1件: Ofatumumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬6件: 11, 13, 35, 46, 222, 223 💬
326OMNIPAQUE----2件: 19, 222 💬
327OMNIPAQUE - 300 MG I/ML SOLUZIONE INIETTABILE FLACONE IN POLIPROPILENE DA 50 ML----1件: 222 💬
328OMS721 (narsoplimab)1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬3件: 66, 222, 223 💬
329Oral Cyclosporine1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 223 💬
330Oral prednisolone and cyclophosphamide2件: Cyclophosphamide,
Prednisolone		3件: Cyclophosphamide ,
Prednisolone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
331ORENCIA----16件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
332Other: All patients will receive CD19 CAR-T cell therapy on the basis of standard symptomatic and supportive treatment.----1件: 222 💬
333Other: Blood sample----37件: 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
334Other: Blood sampling----14件: 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
335Other: Cord-blood mesenchymal stromal cells----1件: 222 💬
336Other: D5W----1件: 222 💬
337Other: excreta----1件: 222 💬
338Other: Measurement of blood immune populations and microbiota distribution.----1件: 222 💬
339Other: Medium Protein Diet (MPD)----1件: 222 💬
340Other: normal saline----5件: 13, 97, 222, 226, 280 💬
341Other: observation of the adverse outcomes of Cyclosporine in steroid dependent and frequent relapsing nephrotic syndrome in children1件: Cyclosporine1件: Cyclosporine 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
342Other: Standard therapy----2件: 49, 222 💬
343Other: tissue sample----1件: 222 💬
344Over-encapsulated 75 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
345Over-encapsulated Irbesartan1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
346Over-encapsulated Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
347Peginterferon alfa-2a1件: Peginterferon alfa-2a1件: Peginterferon alfa-2a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 222 💬
348Peginterferon Alfa-2A 180 MCG/ML Injectable Solution1件: Peginterferon alfa-2a1件: Peginterferon alfa-2a 💬 2件: IFNAR1,
IFNAR2 💬 		18件: Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 222 💬
349Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --13件: 6, 26, 46, 56, 84, 93, 96, 97, 113, 222, 223, 296, 298 💬
350Perindopril1件: Perindopril3件: Perindopril erbumine ,
Perindopril ,
Perindopril arginine 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬5件: 57, 58, 113, 167, 222 💬
351PF-06730512----1件: 222 💬
352Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬 6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬 		83件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬12件: 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
353Plasma exchange----7件: 13, 43, 44, 64, 95, 171, 222 💬
354Plasmapheresis----4件: 11, 49, 113, 222 💬
355Ponticelli Regimen----1件: 222 💬
356Povetacicept1件: Povetacicept1件: Povetacicept 💬 1件: TNFRSF13B 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬5件: 11, 61, 63, 66, 222 💬
357Praliciguat1件: Praliciguat1件: Praliciguat 💬 3件: GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		10件: Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
358Pravastatin1件: Pravastatin2件: Pravastatin sodium ,
Pravastatin 💬 		1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬11件: 13, 46, 49, 67, 79, 96, 164, 210, 222, 265, 333 💬
359Prednisolon----11件: 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
360Prednisolon 5 mg, tabletten----2件: 222, 223 💬
361Prednisolon Mylan 20 mg----2件: 222, 223 💬
362PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
363PREDNISOLONE ACETATE3件: Acetate,
Prednisolone,
Prednisolone acetate		2件: Prednisolone ,
Prednisolone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 222, 223 💬
364Prednisolone and chlorambucil2件: Chlorambucil,
Prednisolone		2件: Chlorambucil ,
Prednisolone 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 222, 223 💬
365Prednisolone and mycophenolate mofetil2件: Mycophenolate mofetil,
Prednisolone		3件: Prednisolone ,
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		3件: Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬2件: 222, 223 💬
366Prednisolone solution 5mg/ml1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 222, 223 💬
367PREDNISONA1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 49, 222 💬
368Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
369Prednisone 0,5 mg/kg orally on alternate days1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 222, 223 💬
370Prednisone 30 mg1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
371Prednisone 45 mg1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
372Prednisone 60 mg/meter square Body Surface Area1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
373Prednisone acetate3件: Acetate,
Prednisone,
Prednisone acetate		2件: Prednisone ,
Prednisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
374Prednisone, ciclosporin and mycophenolate mofetil2件: Mycophenolate mofetil,
Prednisone		3件: Prednisone ,
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬 		3件: IMPDH1,
IMPDH2,
NR3C1 💬 		3件: Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 222 💬
375Prednisone, FK506, MMF1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
376Prednisone,methylprednisone and cyclophosphamide3件: Cyclophosphamide,
Methylprednisone,
Prednisone		3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
377PRIVIGEN----6件: 11, 14, 51, 63, 65, 222 💬
378Privigen 100 mg/ml solution pour perfusion----1件: 222 💬
379Prograf----3件: 60, 222, 226 💬
380Prograff (tacrolimus)1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 223 💬
381Proleukin®----1件: 222 💬
382QT-219CX----3件: 51, 66, 222 💬
383R3R011件: R3R01---2件: 218, 222 💬
384Radiation: Total Body Irradiation----11件: 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
385Ramipril1件: Ramipril1件: Ramipril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬10件: 46, 49, 57, 66, 67, 113, 218, 222, 223, 257 💬
386RE-021----3件: 66, 218, 222 💬
387RE-021 (Sparsentan)1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
388Renin-angiotensin-aldosterone system inhibitors (RASI)1件: Aldosterone1件: Aldosterone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬1件: 222 💬
389Repagermanium----1件: 222 💬
390Repository corticotropin injection1件: Corticotropin2件: Corticotropin ,
Corticotropin, repository 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 2, 13, 46, 84, 222 💬
391Rilzabrutinib1件: Rilzabrutinib1件: Rilzabrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬6件: 35, 61, 63, 222, 223, 300 💬
392Ripertamab1件: Ripertamab---4件: 11, 14, 63, 222 💬
393RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
394Rituximab (genetical recombination)1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 14, 222, 223 💬
395Rituximab Biosimilar1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
396Rituximab Biosimilar ABP 7981件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
397Rituximab combined with corticosteroids1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
398Rituximab combined with tacrolimus induction + rituximab maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬 		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
399Rituximab combined with tacrolimus induction + tacrolimus maintenance2件: Rituximab,
Tacrolimus		3件: Tacrolimus ,
Rituximab ,
Tacrolimus 💬 		6件: MS4A1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
400Rituximab Infusion1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 13, 222, 223 💬
401Rituximab Injection1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬3件: 11, 35, 222 💬
402Rituximab, Cyclophosphamide, and Corticosteroids2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬 		1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
403Rivaroxaban1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬10件: 46, 48, 49, 56, 58, 75, 91, 210, 222, 271 💬
404Rivaroxaban 10 MG1件: Rivaroxaban1件: Rivaroxaban 💬 1件: F10 💬 1件: Complement and coagulation cascades 💬1件: 222 💬
405RIXATHON® 500 mg----1件: 222 💬
406RO0485337----1件: 222 💬
407RO5072759----1件: 222 💬
408Rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬7件: 46, 57, 75, 77, 97, 222, 265 💬
409Rosiglitazone (Avandia)1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 222 💬
410Sacubitril1件: Sacubitril1件: Sacubitril 💬 1件: MME 💬 4件: Alzheimer disease, Hematopoietic cell lineage, Protein digestion and absorption, Renin-angiotensin system 💬4件: 28, 58, 210, 222 💬
411Sample collection----1件: 222 💬
412Sandimmun Neoral----5件: 54, 60, 97, 222, 226 💬
413Saquinavir1件: Saquinavir2件: Saquinavir ,
Saquinavir mesylate 💬 		--4件: 86, 222, 223, 265 💬
414Serine1件: Serine1件: Serine 💬 --5件: 2, 6, 86, 96, 222 💬
415SG301 Subcutaneous injection----1件: 222 💬
416Short-term course (12 week) glucocorticoid regimen----1件: 222 💬
417SHR-2173 injection----5件: 11, 49, 63, 66, 222 💬
418SHR1459 High Dose----1件: 222 💬
419SHR1459 Low Dose----1件: 222 💬
420Single infusion of Obinutuzumab1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
421Single infusion of Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 222 💬
422Sinomenine1件: Sinomenine---2件: 46, 222 💬
423Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬46件: 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
424SK-09----1件: 222 💬
425SNP-ACTH (1-39) Gel----1件: 222 💬
426Sodium succinate1件: Succinic acid---11件: 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
427Solondo----1件: 222 💬
428Somatropin----14件: 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
429SPARSENTAN1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 66, 218, 222, 223 💬
430Sparsentan/Over-encapsulated Sparsentan tablet1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
431Sparsentan/Over-encapsulated Sparsentan tabletProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
432Sparsentan/Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
433Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
434Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
435Sparsentan/Over-encapsulated Sparsentan tabletsProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
436SparsentanProduct Code: RE-021Pharmaceutical Form: Capsule, hardINN or Proposed INN: SparsentanCAS Number: 254740-64-2Current Sponsor code: RE-021Other descriptive name: SPARSENTANConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 200-----1件: 222 💬
437Spironolactone1件: Spironolactone1件: Spironolactone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬12件: 46, 57, 58, 67, 86, 113, 210, 214, 218, 222, 223, 225 💬
438Standard of Care IST----1件: 222 💬
439Standard prednisolone treatment1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 222 💬
440Standard Therapy (ACEI or ARB).----1件: 222 💬
441Steroid----4件: 95, 107, 222, 288 💬
442Steroid & Cyclosporin----1件: 222 💬
443Surovatamig----3件: 46, 49, 222 💬
444Symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin)3件: Aldosterone,
Angiotensin II,
Calcium		4件: Angiotensin II ,
Angiotensin II ,
Aldosterone ,
Angiotensin II acetate 💬 		3件: AGTR1,
AGTR2,
NR3C2 💬 		18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
445Synacthen Depot 1mg----1件: 222 💬
446Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
447Tacrolimus &entecavir2件: Entecavir,
Tacrolimus		4件: Tacrolimus ,
Entecavir ,
Entecavir ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 223 💬
448Tacrolimus (FK506)1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
449Tacrolimus Capsules1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 222, 299 💬
450Tacrolimus combined with prednisone2件: Prednisone,
Tacrolimus		3件: Tacrolimus ,
Prednisone ,
Tacrolimus 💬 		6件: NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		34件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
451Tacrolimus for the treatment of IMN1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
452Tacrolimus Sustained-release Capsules (ADVAGRAF)1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬 		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 222 💬
453Telitacicept1件: Telitacicept---14件: 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
454Telmisartan1件: Telmisartan1件: Telmisartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 6, 57, 66, 67, 222 💬
455Tetracosactide1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 83, 113, 145, 222 💬
456Tetracosactide hexacetaat1件: Tetracosactide2件: Cosyntropin ,
Tetracosactide acetate 💬 		1件: MC2R 💬 6件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 222 💬
457The Comprehensive Treatment Regimen of Traditional Chinese Medicine----1件: 222 💬
458The immunosuppressive agents----1件: 222 💬
459TOLVAPTAN1件: Tolvaptan1件: Tolvaptan 💬 1件: AVPR2 💬 4件: Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬5件: 67, 72, 86, 222, 225 💬
460Torasemide1件: Torasemide1件: Torsemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬1件: 222 💬
461Tripterygium Wilfordii----3件: 46, 67, 222 💬
462Tripterygium wilfordii (TW)----2件: 66, 222 💬
463TRU-0151件: TRU-015---3件: 46, 49, 222 💬
464Truxima----2件: 49, 222 💬
465TRUXIMAB----1件: 222 💬
466TW----1件: 222 💬
467UCAR T-cell----7件: 11, 13, 14, 49, 51, 66, 222 💬
468URBASON*IM EV 1F 250MG+1F 5ML----2件: 222, 223 💬
469Valproic Acid1件: Valproic acid3件: Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		7件: ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		16件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬10件: 3, 5, 26, 34, 65, 89, 90, 145, 222, 331 💬
470Valsartan1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬
471Valsartan (VAL489)1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 222 💬
472VB119----1件: 222 💬
473VIS171----2件: 49, 222 💬
474Vitamin D1件: Vitamin D---26件: 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
475Vitamin K 2----1件: 222 💬
476Voclosporin1件: Voclosporin1件: Voclosporin 💬 5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬2件: 49, 222 💬
477VX-147----1件: 222 💬
478VX147----1件: 222 💬
479WAL0921----1件: 222 💬
480Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬15件: 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
481Warfarin Sodium1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 48, 49, 222 💬
482YK012----2件: 49, 222 💬
483Zanubrutinib1件: Zanubrutinib1件: Zanubrutinib 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬7件: 13, 48, 61, 63, 222, 300, 331 💬
484Zestril----3件: 19, 67, 222 💬
485Zinc1件: Zinc---7件: 2, 56, 85, 171, 222, 223, 299 💬
486Zinc supplementation plus standard treatment1件: Zinc---1件: 222 💬
487ZUBERITAMAB1件: ZUBERITAMAB---2件: 63, 222 💬
488Zuberitamab 1000mg1件: ZUBERITAMAB---1件: 222 💬
489Zuberitamab 600mg1件: ZUBERITAMAB---1件: 222 💬
490 LNP023 HYDROCHLORIDE SALT----7件: 61, 62, 63, 66, 109, 222, 223 💬